Objective: To assess the efficacy of transcranial direct current stimulation (tDCS) on improving consciousness in patients with persistent unresponsive wakefulness syndrome (UWS) (previously termed persistent vegetative state [PVS]) or in...
more
Objective: To assess the efficacy of transcranial direct current stimulation (tDCS) on improving consciousness in patients with persistent
unresponsive wakefulness syndrome (UWS) (previously termed persistent vegetative state [PVS]) or in a minimally conscious state (MCS).
Design: Prospective, case series trial with follow-up at 12 months.
Setting: General and research hospital.
Participants: Inpatients in a PVS/UWS or MCS (NZ10; 7 men, 3 women; age range, 19e62y; etiology: traumatic brain injury, nZ5; anoxia,
nZ4; postoperative infarct, nZ1; duration of PVS/UWS or MCS range, 6moe10y). No participant withdrew because of adverse effects.
Intervention: All patients received sham tDCS for 20 minutes per day, 5 days per week, for 1 week, and real tDCS for 20 minutes per day, 5 days
per week, for 2 weeks. An anodal electrode was placed over the left primary sensorimotor cortex or the left dorsolateral prefrontal cortex, with
cathodal stimulation over the right eyebrow. One patient in an MCS received a second round of 10 tDCS sessions 3 months after initial
participation.
Main Outcome Measure: JFK Coma Recovery Scale-Revised.
Results: All patients in an MCS showed clinical improvement immediately after treatment. The patient who received a second round of tDCS 3
months after initial participation showed further improvement and emergence into consciousness after stimulation, with no change between
treatments. One patient who was in an MCS for <1 year before treatment (postoperative infarct) showed further improvement and emergence into
consciousness at 12-month follow-up. No patient showed improvement before stimulation. No patient in a PVS/UWS showed immediate
improvement after stimulation, but 1 patient who was in a PVS/UWS for 6 years before treatment showed improvement and change of status to an
MCS at 12-month follow-up.
Conclusions: tDCS seems promising for the rehabilitation of patients with severe disorders of consciousness. Severity and duration of pathology
may be related to the degree of tDCS’ beneficial effects.